top of page

RUSSELL RYAN LAB

Targeting cancer gene regulation in lymphoid malignancies

07202022_CSC_Russell_Ryan_Lab_Photos-1142.jpg
Home: Overview

RESEARCH

Flipping the switch on driver oncogenes

Home: Research
s13-23280 HE 8.jpg

B CELL LYMPHOMAS AND LEUKEMIAS

Cancers that develop from B cells affect patients of all ages, and are diverse in their biology and clinical behavior. By uncovering the unique dependencies of specific leukemia and lymphoma subtypes, we seek to define more effectively tailored treatment strategies for individual cancer patients.

ONCOGENE ENHANCERS

We use a combination of genome-wide chromatin profiling technologies and high-throughput Cas9-based functional screening approaches to dissect the mechanisms that sustain expression of genes critical for the growth and survival of lymphoid cancers

4C_zoom_1.jpg
Notch_muts_zoom_1.jpg

NOTCH SIGNALING

Mutations in Notch receptor genes are recurrent in several types of lymphoid cancer, but the mechanisms by which Notch drives mature B cell lymphomas remains poorly understood. We identified genome-wide direct targets of Notch in mature B cell cancers, and are working to understand the process by which the Notch regulome sustains lymphoma.

Want to learn more about our research projects?

Contact Us

NEWS

What we're up to

CONGRATULATIONS ASHWIN!

July 2023

Ashwin Iyer successfully defended his PhD thesis on enhancer dependencies in MYC-intact and MYC-rearranged Diffuse Large B-cell Lymphoma.

Ashwin defense group 1.jpeg

WE'RE MOVING!

September 2018

The Ryan lab is moving from the LSI to our new home on the 4th floor of the Rogel Cancer Center building. We're excited to be located in the heart of the U-M Medical Campus, and to explore collaborations with our new neighbors in Pathology and Hematology-Oncology.

Cancer_Center_Photo_2.jpg
Home: News & Resources

LAB MEMBERS

Home: Lab Members
Russell_Ryan-3.jpg

RUSSELL RYAN, MD

Principal Investigator

Alec headshot.png

ALEC MONOVICH

Graduate Student - Molecular & Cellular Pathology

Ryan Lab-11.jpg

ASHWIN IYER

Graduate Student - Molecular & Cellular Pathology

07202022_CSC_Aishwarya_Gurumurthy_Headshot-1187.jpg

AISHWARYA GURUMURTHY, PHD

Postdoctoral Fellow

07202022_CSC_Joshua_Goldman_Headshot-1166.jpg

JOSHUA GOLDMAN, MD

Pediatric Hematologist

07202022_CSC_Rachel_Aguilar_Headshot-1204.jpg

ATHALEE AGUILAR

Technician / Lab Manager

Ashwin defense group 2.jpeg

ARVIND EMMANUEL

Undergraduate Student

SELECTED PUBLICATIONS

Home: Publications
DLBCL_MYC_enhancer_strategy_v2.png

SELECTIVE ENHANCER DEPENDENCIES IN MYC-INTACT AND MYC-REARRANGED GERMINAL CENTER B-CELL DIFFUSE LARGE B-CELL LYMPHOMA

We used custom high-throughput CRISPR-interference screens to identify essential enhancers in the MYC locus and MYC rearrangement partner loci, identifying novel regulators of MYC expression in diffuse large B-cell lymphoma

GGAA_rep_enhancers.png

ETV6 DEFICIENCY UNLOCKS ERG-DEPENDENT MICROSATELLITE ENHANCERS TO DRIVE ABERRANT GENE ACTIVATION IN B-LYMPHOBLASTIC LEUKEMIA

We identified conversion of GGAA tandem repeat elements into active enhancers as a key mechanism underlying the leukemia-specific gene expression program of a common form of childhood leukemia.

CLL_PBL.png

A B CELL REGULOME LINKS NOTCH TO DOWNSTREAM ONCOGENIC PATHWAYS IN SMALL B CELL LYMPHOMAS

We identified Notch as a direct activator of the 5' MYC enhancers in mantle cell lymphoma, and identified a genome-wide set of direct functional Notch target genes relevant to the biology of mantle cell lymphoma and chronic lymphocytic leukemia. Collaborative work with the laboratories of Dr. Bradley Bernstein, Warren Pear, and Jon Aster.

Pear-ChIP logo.png

DETECTION OF ENHANCER-ASSOCIATED REARRANGEMENTS REVEALS MECHANISMS OF ONCOGENE DYSREGULATION IN B-CELL LYMPHOMA

We used a novel approach to simultaneously identify enhancer activity and genomic rearrangements across diverse lymphoma subtypes. In lymphomas lacking rearrangements of the oncogenes MYC and BCL6, lymphoma subtype- and tissue-specific distal enhancers were associated with oncogene activation. Work conducted in the laboratory of Dr. Bradley Bernstein.

CLL_prolif_center_zoom_2_br.png

July 12, 2023

I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add your own content and make changes to the font. I’m a great place for you to tell a story and let your users know a little more about you.

FORMER LAB MEMBERS

Home: Lab Members
Ryan Lab-06.jpg

JUHI GUPTA

Now: Medical School, University of Chicago

Russell Ryan Lab-4.jpg

CODY HALL

Now: Medical School, Central Michigan University

Russell Ryan Lab-2.jpg

TRAVIS SAARI

Now: Bioinformatics Core, University of Michigan

CONTACT US

1500 E Medical Center Dr.   
Rogel Cancer Center, Room 4130
Ann Arbor, MI 48109-5936

rjhryan [at] med.umich.edu

P: 734-936-2499

F: 734-763-2162

  • Twitter
Home: Contact
bottom of page